Nuclear proteome analysis of cisplatin-treated HeLa cells
Authors:
- Chunlan YanCYChunlan Yan
- Penelope J. Duerksen-HughesPenelope J. Duerksen-Hughes
- Xinqiang ZhuXZXinqiang Zhu
- Jun YangJYJun Yang
- 1 September 2010
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 691 (1-2) , 1-8
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30771826, 30872140)
- Ministry of Science and Technology of the People's Republic of China (2009DFB30390)
- Science and Technology Department of Zhejiang Province (2009C11122)
- Fok Ying Tung Education Foundation (101036)
- Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
This publication has 48 references indexed in Scilit:
- Mechanism of the formation of DNA–protein cross-links by antitumor cisplatinNucleic Acids Research, 2007
- A comparative study of using comet assay and γH2AX foci formation in the detection of N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA damageToxicology in Vitro, 2006
- Activation of p38 MAP kinase by DNA double‐strand breaks in V(D)J recombination induces a G2/M cell cycle checkpointThe EMBO Journal, 2006
- Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer ModelsJournal of Biological Chemistry, 2004
- p53 protects from replication-associated DNA double-strand breaks in mammalian cellsOncogene, 2004
- Regulation of Ionizing Radiation-induced Rad52 Nuclear Foci Formation by c-Abl-mediated PhosphorylationJournal of Biological Chemistry, 2002
- Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in VivoJournal of Cell Biology, 1999
- Metal Antitumor Compounds: The Mechanism of Action of Platinum Complexes1989
- The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexesPharmacology & Therapeutics, 1987
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969